NASDAQ · Medical - Instruments & Supplies

Singular Genomics Systems, Inc. (OMIC) Stock

$20.01 +0.00% NASDAQ: OMIC Healthcare

Singular Genomics Systems, Inc. is a life science technology firm focused on creating advanced next-generation sequencing and multiomics solutions.

Valuation

MetricValue
Price$20.01
Market Cap$50.77M
P/E Ratio-0.51
P/B Ratio0.27
P/S Ratio17.44
EPS (TTM)$-39.08
52-Week High$23.41
52-Week Low$5.34
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-43.17%
ROA-35.72%
ROCE-41.59%
Gross Margin-19.17%
Operating Margin-3433.33%
Net Margin-3166.67%
Debt/Equity0.42
Current Ratio10.51

Annual Financials (USD)

Metric20192020202120222023
Revenue$0$0$0$1.0M$3.0M
Operating Profit$-13.0M$-28.0M$-61.0M$-93.0M$-103.0M
Net Profit$-12.0M$-29.0M$-99.0M$-88.0M$-95.0M
EPS$-5.34$-12.41$-40.95$-37.22$-39.08
Op Margin———-12220.5%-3531.5%

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$48.0M$31.0M$356.0M$328.0M$265.0M
Total Liabilities$73.0M$82.0M$19.0M$68.0M$86.0M
Cash$6.0M$12.0M$201.0M$74.0M$16.0M
Borrowings$2.0M$9.0M$10.0M$59.0M$75.0M

Latest News

AbCellera reports favourable Phase II data for ABCL635 Hospital Management · Aug 11, 2026 Kaiser Permanente commits $25 million to Martin Luther King Jr. Community Hospital PR Newswire · Aug 11, 2026 11 banks join Hai Long project financing Energy Global · Aug 11, 2026 Mortgage and refinance rates today, Tuesday, August 11, 2026: Rates mostly higher as U.S. 'low-keying' Iran negotiations Yahoo Personal Finance · Aug 11, 2026 TURPAZ INDUSTRIES LTD. ANNOUNCES RECORD SECOND QUARTER AND FIRST HALF 2026 RESULTS PR Newswire · Aug 11, 2026

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$-11.0M$-25.0M$-52.0M$-87.0M$-74.0M
Investing Cash Flow$-32.0M$23.0M$-136.0M$-46.0M$13.0M
Financing Cash Flow$0$0$4.0M$1.0M$1.0M
Net Cash Flow$4.0M$7.0M$190.0M$-126.0M$-59.0M
Free Cash Flow$-12.0M$-26.0M$-57.0M$-93.0M$-75.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.09
EV / EBITDA-1.27
FCF Yield-146.98%
Quick Ratio9.77
Interest Coverage-93.37
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Singular Genomics Systems, Inc.

Singular Genomics Systems, Inc. is a life science technology firm focused on creating advanced next-generation sequencing and multiomics solutions. The company aims to provide researchers and clinicians with innovative tools to accelerate scientific discovery and medical advancements. Among its core products is the G4 Instrument, a compact next-generation sequencer designed to deliver genetic sequencing results, supported by a selection of complementary consumable kits. Singular Genomics also offers the PX Integrated Solution, a versatile multiomics platform that consolidates single-cell analysis, spatial analysis, genomics, and proteomics into a single, unified instrument. To ensure broad compatibility for the G4, the company maintains strategic partnerships with entities like Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics for the validation of their library preparation kits. Additionally, a collaboration with the Broad Institute of MIT and Harvard enables the G4's integration with the Terra data platform. Established in 2016, Singular Genomics Systems, Inc. is headquartered in La Jolla, California.

Singular Genomics Systems, Inc. is headquartered in US.

Singular Genomics Systems, Inc. (OMIC) stock trades at $20.01 with a market capitalization of $50.77M. The stock is valued at a price-to-earnings (P/E) ratio of -0.51, price-to-book of 0.27, price-to-sales of 17.44. Over the past 52 weeks the stock has ranged between $5.34 and $23.41, and currently trades 14.5% below its 52-week high.

On profitability, Singular Genomics Systems, Inc. generates a return on equity (ROE) of -43.17%, return on capital employed of -41.59%, an operating margin of -3433.33%, a net profit margin of -3166.67%.

Official website: singulargenomics.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides